Indivior (OTCMKTS:INVVY – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Thursday, Zacks.com reports. According to Zacks, “Indivior PLC operates as a specialty pharmaceutical company. It is engaged in discovering and developing medications and treatment for alcohol addiction, opioid overdose, […]
Zacks Investment Research Lowers Indivior (OTCMKTS:INVVY) to Hold
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Study of DSUVIA® Showing Significant Reduction in Postoperative Opioids and Better OBAS Scores Compared to Control Group to be Presented at the American Society of Regional Anesthesia (ASRA) Annual Meeting
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
- With the indication expanded to pediatric patients, ALK Canada now provides adults and children a SLIT-tablet option to treat allergies to ragweed pollen, one of the most common allergens found in the provinces of Ontario and Quebec -
MISSISSAUGA, ON, Dec. 22, 2020 /CNW/ Today ALK, a global, research-driven pharmaceutical company, announced that Health Canada has approved once-daily RAGWITEK® (Standardized Allergen Extract, Short Ragweed (Ambrosia artemisiifolia) Sublingual Tablet) for the treatment of moderate to severe ragweed pollen allergies in children age five and older. RAGWITEK had received Health Canada approval for adult use in 2014.
2.2.1 Mechanism of Immunotherapy
2.3 Allergy Immunotherapy Segmentation: An Overview
2.3.1 Allergy Immunotherapy Segmentation
3. Global Market Analysis
3.1.1 Global Allergy Immunotherapy Market by Value
3.1.2 Global Allergy Immunotherapy Market by Method of Administration (Subcutaneous, Sublingual Solution, and Sublingual Tablet)
3.1.3 Global Allergy Immunotherapy Market by Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Skin Allergy, Eye Allergy, and Other Allergies)
3.1.4 Global Allergy Immunotherapy Market by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Other Channels)
3.1.5 Global Allergy Immunotherapy Market by Region (Europe, the US, and Rest of the World)
3.2 Global Allergy Immunotherapy Market: Method of Administration Analysis
3.2.1 Global Subcutaneous Allergy Immunotherapy Market by Value
3.2.2 Global Sublingual Allergy Immunotherapy Solution Market by Value